Statistics

Total Visits

	Views
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations	8

File Visits

	Downloads
1060.pdf	3

Select a period of time:

Number of views in the range

	Views
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations	8

Number of downloads in the range

	Downloads
1060.pdf	3

Views

	Views
July 2025	0
August 2025	0
September 2025	0
October 2025	3
November 2025	3
December 2025	2
January 2026	0

untranslated

untranslated

Number of downloads in the period of time

Downloads
July 2025

0
August 2025

0
September 2025

0
October 2025

0
November 2025

2
December 2025

1
January 2026

0

untranslated

untranslated

Top country views

	Views
Argentina	2
Benin	1
Brazil	1
Germany	1
Honduras	1
Netherlands	1
Paraguay	1

Top countries by downloads

	Downloads

Top cities views

	Views
Buenos Aires	1
Elburg	1
Hamburg	1
Rio de Janeiro	1
San Juan Bautista	1
Tegucigalpa	1

Top cities by downloads

	Downloads